Corrigendum to "Re: Pathologic complete responses, long-term outcomes, and recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy in breast cancer" [Eur J Cancer 180 (2023) 184-185]

Eur J Cancer. 2024 Mar:200:113559. doi: 10.1016/j.ejca.2024.113559. Epub 2024 Feb 2.
No abstract available

Publication types

  • Published Erratum